Apo Aporosa

Apo Aporosa

Auto-generated profile, based on publicly available information

Apo Aporosa

University of Waikato

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2020 in Human Psychopharmacology: Clinical and Experimental
Verified
Journal Article
Open access
PDF file
AAApo S. Aporosa
Apo S. Aporosa
MAMartin Atkins
Martin Atkins
RBRichard Brunton
Richard Brunton
Background: Kava drinking is a tradition among Pacific Island people, although growing in popularity with other ethnicities. However, drinking substantial quantities of kava has raised concerns regarding physical manifestations of slow response and lack of precision in bodily control. These impairments can have significant consequences when after consuming large volumes of kava an individual makes a choice to drive.Aims: The objective of this study was to measure selected cognitive functions following high traditionally consumed kava volumes (greater than 2,000 mg of kavalactones) aimed at identifying potential risks for kava drink‐drivers.Methods: The reaction and divided attention of 20 control participants was assessed against 20 active kava‐drinking participants during and following a 6‐hr kava session in a “naturalised” setting. Assessment measures were drawn from Vienna Test System—Traffic's test battery.Results/Outcomes: Results showed no statistical significant difference between control and active participants at any measurement point over a 6‐hr testing period regardless that the movements and speech of the active participants were observed to slow as the test session and kava consumption progressed.Conclusion: Inconsistencies between test results and observations during testing and by road policing officers demonstrate an urgent need for more research in this field.

1 January 2019 in Drug Science, Policy and Law
Verified
Journal Article
Open access
PDF file
SAS Apo Aporosa
S Apo Aporosa
What seemed impossible 50 years ago is today becoming a reality as ‘soft drugs’ such as cannabis are being decriminalized and accepted for their calming effects as well as their legitimate medicinal properties. Several countries have now made the possession of cannabis legal, with others considering this, while the coffee shops in the Netherlands have been supplying cannabis in different forms for many years. It is now the turn of kava to be re-evaluated, to see whether there are properties in this plant that might be readily substituted for more conventional and harmful drugs, for instance tobacco and alcohol. However, as highlighted by Norton and Ruze (1994), kava like cannabis, has an enduring reputation that still makes it difficult for many to accept. Kava has been mythologized as an illicit alcohol, highly addictive, and causing physical harm. When examining the history of kava use in traditional contexts and considering the evidence now available, it is possible to demythologize this characterization. Looking at the potential benefits, it is time to re-brand kava, not only on the grounds as a relaxant, but in possessing life enhancing medicinal properties and as an alternative to alcohol, understanding that will be beneficial to policy makers, doctors and pharmacists.

10 February 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SAS. 'APo' Aporosa
S. 'APo' Aporosa
HBHakau Ballard
Hakau Ballard
RPRishi Pandey
Rishi Pandey
MMMary Jane McCarthy
Mary Jane McCarthy

27 May 2025 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
SAS Aporosa
S Aporosa
DIDennis Itoga
Dennis Itoga
JIJulia Ioane
Julia Ioane
JPJan Prosser
Jan Prosser
SVSione Vaka
Sione Vaka
HTHelen Turner
Helen Turner
Levels of post-traumatic stress disorder (PTSD), trauma-related distress, and subsyndromal PTSD, (here “PTS”) among combat soldiers and first responders are of international concern. In the broader population, a PTS global epidemic is attending trauma associated with the threatscape of the Anthropocene (increased extreme weather events, natural disasters, conflict, rising poverty, emerging infectious disease) as well as the legacy of the COVID-19 pandemic. PTS is also a health economic burden, with costs associated with treatment, long-term morbidity, and increased risk of mortality. In the Pacific region, rising PTS is associated with the existential threat of climate change and the economic and social legacy of colonization. There is an unmet therapeutic need for improved and culturally aligned PTS therapies in the Pacific and beyond. Medical standards of care for anxiety/PTS typically involve psychotropic interventions such as benzodiazepines (BDZ), tricyclic anti-depressants and anti-psychotic medications which have addictive potential, are only effective in the short term, are contraindicated for key populations such as the elderly and have significantly problematic track records in indigenous populations. Moreover, systemic racism both drives PTS in indigenous and other marginalized populations and limits the efficacy in such populations of conventional PTS therapies which are not culturally relevant or informed. Here, we describe the development of a novel, but traditionally grounded, approach to PTSD symptomatology in the context of Pacific populations. This approach has two elements: kava is a culturally significant Pacific drink used traditionally and in cultural practice, as a relaxant, to promote dialog in group settings, to aid in sleep and to manage anxiety. Its anxiolytic and sedative properties may link to the presence of kavalactones which are putative low potency γ-aminobutyric acid (GABA) ligands. Talanoa is a dialog practice common to most Pacific cultures. Our core hypothesis is that, combined, kava-talanoa will outperform current standards of care in PTSD symptom management as a culturally augmented cognitive-behavioral group therapy intervention. In this paper we review supporting literature, describe kava-talanoa pilot study findings and planned clinical trials, discuss important open questions, and present recommendations for broad-based transcultural applicability of this approach to global PTS burdens.

5 July 2021
Verified
Journal Article
Open access
PDF file
THTodd M Henry
Todd M Henry
SAS. Apo Aporosa
S. Apo Aporosa
Covid-19 has had a major impact on collectivist cultures and their means of social interaction and maintaining contact with those in their wider community. This has particularly been the case for Pacific peoples living in diaspora, with Covid-19 preventing travel home and social distancing and forced lockdowns restricting the ability to gather. This has also impacted vā, the Pacific concept of 'relational space' critical to connectivity and maintaining relationships. This paper explains the creation of virtual faikava; online meeting environments in which Pacific kava users meet, maintain vā, connect with those at home and in the wider diasporic community and learn, while consuming their traditional beverage kava.

23 July 2019
Verified
Book Chapter
Closed access
PDF file
SAS. Apo Aporosa
S. Apo Aporosa